Mainz Biomed B.V.
MYNZ · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$21,651 | -$26,296 | -$26,387 | -$11,690 |
| Dep. & Amort. | $1,017 | $866 | $380 | $70 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,136 | $4,006 | $9,824 | $6,430 |
| Change in WC | $52 | -$65 | -$437 | -$139 |
| Other Non-Cash | $2,355 | -$451 | $1,851 | $2,108 |
| Operating Cash Flow | -$17,090 | -$21,939 | -$14,770 | -$3,220 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$105 | -$1,199 | -$658 | -$17 |
| Net Acquisitions | $33 | $0 | $0 | $1,220 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$127 | -$700 | $0 | $0 |
| Investing Cash Flow | -$199 | -$1,899 | -$658 | $1,203 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $2,835 | $7,834 | -$198 | $185 |
| Stock Issued | $13,765 | $6,393 | $24,248 | $10,425 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$107 | $0 |
| Financing Cash Flow | $16,600 | $14,227 | $23,943 | $10,611 |
| Forex Effect | -$146 | -$460 | -$101 | $12 |
| Net Chg. in Cash | -$835 | -$10,071 | $8,414 | $8,605 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,071 | $17,142 | $8,728 | $123 |
| End Cash | $6,236 | $7,071 | $17,142 | $8,728 |
| Free Cash Flow | -$17,345 | -$23,838 | -$15,428 | -$3,237 |